tumour line" and line 7 from the bottom "CD8F 7 breast tumour lines". The same applies to page 90, left-hand column, line 3. The dosages of LV in this paragraph are in mg/m 2.
The last sentence on page 92 should be: "A dosedependent increase of pyrimidine nucleoside phosphorylase activity was caused by interferon-~ [79]; uridine phosphorylase activity also increased after interferon~a [90] ."
On page 94, left-hand column, line 12-13 should have read "... could not be modulated by interferona [43] ." The last sentence of the left-hand column should read "The number of cell lines for which interferon-fl acts...".
On page 98, line 13-14 from the bottom should read "... allow the cell to grow and divide [110] ."
On page 100 the last sentence of the first paragraph should be changed to: "ICI D1694 (Tomudex) has been evaluated in several phase I trials [131] 
